National Health (Weighted average disclosed price – third transitional disclosure cycle) Amendment Determination 2012 (No. PB 51 of 2012) (Cth)

Case

PB 51 of 2012

National Health (Weighted average disclosed price – third transitional disclosure cycle) Amendment Determination 2012

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated         20 July 2012

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

  1. Name of Determination

(1)     This Determination is the National Health (Weighted average disclosed price – third transitional disclosure cycle) Amendment Determination 2012.

(2)     This Determination may also be cited as PB 51 of 2012.

  1. Commencement

This Determination commences on the day after it is registered.

3              Amendments to PB 12 of 2012

Schedule 1 amends the National Health (Weighted average disclosed price – third transitional disclosure cycle) Determination 2012 (PB 12 of 2012).

Schedule 1             Amendments

[1]      Schedule 1, After

17 Bisoprolol Tablet containing bisoprolol fumarate 10 mg Oral APO-Bisoprolol 44.24 47.57

insert:

17A Bisoprolol Tablet containing bisoprolol fumarate 10 mg Oral Beprol 10 44.24 47.57

[2]      Schedule 1, After

19 Bisoprolol Tablet containing bisoprolol fumarate 10 mg Oral Bicor 44.24 47.57

insert:

19A Bisoprolol Tablet containing bisoprolol fumarate 10 mg Oral Biso 10 44.24 47.57

[3]      Schedule 1, After

26 Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral APO-Bisoprolol 28.32 30.45

insert:

26A Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Beprol 2.5 28.32 30.45

[4]      Schedule 1, After

28 Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Bicor 28.32 30.45

insert:

28A Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Biso 2.5 28.32 30.45

[5]      Schedule 1, After

35 Bisoprolol Tablet containing bisoprolol fumarate 5 mg Oral APO-Bisoprolol 35.39 38.05

insert:

35A Bisoprolol Tablet containing bisoprolol fumarate 5 mg Oral Beprol 5 35.39 38.05

[6]      Schedule 1, After

37 Bisoprolol Tablet containing bisoprolol fumarate 5 mg Oral Bicor 35.39 38.05

insert:

37A Bisoprolol Tablet containing bisoprolol fumarate 5 mg Oral Biso 5 35.39 38.05

[7]      Schedule 1, After

47 Doxorubicin Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial Injection/intravesical Accord Doxorubicin 4.61 4.96

omit:

48 Doxorubicin Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial Injection/intravesical Adriamycin Solution 4.61 4.96

[8]      Schedule 1, After

51 Doxorubicin Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 100 mg in 50 mL single dose vial Injection/intravesical Doxorubicin Ebewe 38.97 41.90

omit:

52 Doxorubicin Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 20 mg in 10 mL single dose vial Injection/intravesical Adriamycin Solution 8.24 8.86

[9]      Schedule 1, After

88 Levetiracetam Tablet 1 g Oral Keppra 96.84 104.12

insert:

88A Levetiracetam Tablet 1 g Oral Kerron 1000 96.84 104.12

[10]    Schedule 1, After

99 Levetiracetam Tablet 250 mg Oral Keppra 34.86 37.48

insert:

99A Levetiracetam Tablet 250 mg Oral Kerron 250 34.86 37.48

[11]    Schedule 1, After

110 Levetiracetam Tablet 500 mg Oral Keppra 58.12 62.49

insert:

110A Levetiracetam Tablet 500 mg Oral Kerron 500 58.12 62.49

[12]    Schedule 1, After

149 Meloxicam Tablet 7.5 mg Oral Terry White Chemists Meloxicam 7.5 mg 6.82 7.33

omit:

150 Mitozantrone Injection 10 mg (as hydrochloride) in 5 mL Injection Pfizer Australia Pty Ltd 53.34 57.35

[13]    Schedule 1, After

155 Mitozantrone Injection 25 mg (as hydrochloride) in 12.5 mL Injection Onkotrone 133.29 143.31

omit:

156 Mitozantrone Injection 25 mg (as hydrochloride) in 12.5 mL Injection Pfizer Australia Pty Ltd 133.29 143.31

[14]    Schedule 1, After

160 Ondansetron I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL Injection Onsetron 1.93 2.08

omit:

161 Ondansetron I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL Injection Pfizer Australia Pty Ltd 1.93 2.08

[15]    Schedule 1, After

166 Ondansetron I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL Injection Onsetron 3.06 3.29

omit:

167 Ondansetron I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL Injection Pfizer Australia Pty Ltd 3.06 3.29

[16]    Schedule 1, After

174 Oxaliplatin Powder for I.V. infusion 100 mg Injection Oxaliplatin Link 79.14 85.09

omit:

175 Oxaliplatin Powder for I.V. infusion 100 mg Injection Winthrop Oxaliplatin 79.14 85.09

[17]    Schedule 1, After

185 Oxaliplatin Solution concentrate for I.V. infusion 100 mg in 20 mL Injection Eloxatin 79.14 85.09

insert:

185A Oxaliplatin Solution concentrate for I.V. infusion 100 mg in 20 mL Injection Oxaliccord 79.14 85.09

[18]    Schedule 1, After

191 Oxaliplatin Solution concentrate for I.V. infusion 50 mg in 10 mL Injection Eloxatin 40.97 44.05

insert:

191A Oxaliplatin Solution concentrate for I.V. infusion 50 mg in 10 mL Injection Oxaliccord 40.97 44.05

[19]    Schedule 2, After

10 Fosinopril with Hydrochlorothiazide Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg Oral APO-Fosinopril HCTZ 10/12.5 11.38

omit:

11 Fosinopril with Hydrochlorothiazide Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg Oral Fosinopril/HCT Sandoz 10mg/12.5mg 11.38

[20]    Schedule 2, After

16 Fosinopril with Hydrochlorothiazide Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg Oral Fosetic 20/12.5 16.72

omit:

17 Fosinopril with Hydrochlorothiazide Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg Oral Fosinopril/HCT Sandoz 20mg/12.5mg 16.72

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0